Stockscreener 앱 받기
6.70
2.76%
-0.19
시간 외 거래:
6.51
-0.19
-2.84%
전일 마감가:
$6.89
열려 있는:
$6.73
하루 거래량:
10,521
Relative Volume:
0.02
시가총액:
$10.71M
수익:
$1.47M
순이익/손실:
$-97.61M
주가수익비율:
-4.4966
EPS:
-1.49
순현금흐름:
$-80.90M
1주 성능:
+1.82%
1개월 성능:
-27.57%
6개월 성능:
-28.34%
1년 성능:
-56.45%
1일 변동 폭
$6.56
$7.08
1주일 범위
$6.5441
$7.20
52주 변동 폭
$3.8101
$37.50
Lyra Therapeutics Inc Stock (LYRA) Company Profile
명칭
Lyra Therapeutics Inc
전화
617-373-4600
주소
480 ARSENAL WAY, WATERTOWN, MA
LYRA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LYRA
Lyra Therapeutics Inc
|
6.70 | 10.84M | 1.47M | -97.61M | -80.90M | -1.49 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Lyra Therapeutics Inc Stock (LYRA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-05-07 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2024-05-07 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-05-07 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-05-06 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-10-06 | 재개 | BTIG Research | Buy |
| 2023-08-31 | 개시 | H.C. Wainwright | Buy |
| 2022-05-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-05-26 | 개시 | BTIG Research | Buy |
| 2020-05-26 | 개시 | BofA/Merrill | Buy |
| 2020-05-26 | 개시 | Jefferies | Buy |
| 2020-05-26 | 개시 | William Blair | Outperform |
모두보기
Lyra Therapeutics Inc 주식(LYRA)의 최신 뉴스
Predicting Lyra Therapeutics Inc. trend using moving averagesFree AI Powered High Return Stock Calls - Newser
Building trade automation scripts for Lyra Therapeutics Inc.Investment Position Summary with Timeframe Forecast - Newser
What earnings revisions data tells us about Lyra Therapeutics Inc.Free Entry Alert With Low Drawdown Strategy - Newser
Chart overlay techniques for tracking Lyra Therapeutics Inc.Institutional Holding Behavior Pattern Analysis - Newser
Using economic indicators to assess Lyra Therapeutics Inc. potentialReal Chart Based Opportunity Identification - Newser
Will Lyra Therapeutics Inc. rebound enough to break evenConsistent Gain Plan with AI Support - Newser
Why Lyra Therapeutics Inc. stock attracts strong analyst attentionPredictable Return Strategy with AI Support - Newser
How to use a screener to detect Lyra Therapeutics Inc. breakoutsWeekly High Conviction Trade Setup Analysis - Newser
Can trapped investors hope for a rebound in Lyra Therapeutics Inc.Free Community Strategy With High Win Rate - Newser
Risk vs reward if holding onto Lyra Therapeutics Inc.Automated AI Forecast with Trading Alerts - Newser
Is Lyra Therapeutics Inc. stock poised for growthSmart Risk Strategy with Entry Optimization - Newser
Custom strategy builders for tracking Lyra Therapeutics Inc.Free Entry and Exit Strategy Optimizer Tool - Newser
Lyra Therapeutics Inc expected to post a loss of $6.02 a shareEarnings Preview - TradingView
Real time breakdown of Lyra Therapeutics Inc. stock performanceMarket Forecast Summary Over Multi-Year Period - Newser
Published on: 2025-08-06 20:20:47 - Newser
What makes Lyra Therapeutics Inc. stock price move sharplyBreakout Monitoring with Momentum Analysis - Newser
What to do if you’re stuck in Lyra Therapeutics Inc.Free AI Based High Gain Watchlist Scanner - Newser
Real time alert setup for Lyra Therapeutics Inc. performanceFree Market Momentum and Signal Alerts - Newser
Is it the right time to buy Lyra Therapeutics Inc. stockGet expert analysis on top stock picks - Jammu Links News
Real time scanner hits for Lyra Therapeutics Inc. explainedHigh Yield Watchlist with Filtered Picks - Newser
Is Lyra Therapeutics Inc. stock overvalued or undervaluedInvest smarter with actionable trading signals - Jammu Links News
Should I hold or sell Lyra Therapeutics Inc. stock in 2025Free Investment Risk Control - Jammu Links News
What catalysts could drive Lyra Therapeutics Inc. stock higher in 2025Free Predictions - Jammu Links News
Why is Lyra Therapeutics Inc. stock attracting strong analyst attentionBuild wealth with high-performing stocks - Jammu Links News
When is Lyra Therapeutics Inc. stock expected to show significant growthCapitalize on fast-growing stocks today - Jammu Links News
What drives Lyra Therapeutics Inc. stock priceUnlock exclusive stock market forecasts - Jammu Links News
Key resistance and support levels for Lyra Therapeutics Inc.Real-Time AI Sentiment and Price Forecast - newser.com
What is the dividend policy of Lyra Therapeutics Inc. stockCapitalize on market trends with confidence - Jammu Links News
What analysts say about Lyra Therapeutics Inc. stockMaximize gains with timely market signals - Jammu Links News
What are the latest earnings results for Lyra Therapeutics Inc.Invest confidently with professional market insights - Jammu Links News
Is a relief rally coming for Lyra Therapeutics Inc. holdersSwing Trade Timing with Daily Forecast - Newser
What are Lyra Therapeutics Inc. company’s key revenue driversDaily Trading Strategy To Watch Now - Jammu Links News
Is it time to cut losses on Lyra Therapeutics Inc.Breakout Screener With Alert Based Timing - Newser
Competitive Positioning of Lyra Therapeutics Inc.: Is It Leading or LaggingMulti-Year Signal Summary and Entry Timing - Newser
Is Lyra Therapeutics Inc. stock reversal real or fakeTrading Opportunities Forecast by AI Insight - Newser
Buy Signal for Lyra Therapeutics Inc. Stock Key Technical Indicators to WatchWeekly Gain Forecast with Momentum Indicators - Newser
Should you wait for a breakout in Lyra Therapeutics Inc.Weekly Return Plan for Conservative Traders - Newser
Lyra Therapeutics Inc (LYRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):